These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7720517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
    Ekström G, Gunnarsson UB.
    Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
    [Abstract] [Full Text] [Related]

  • 3. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [Abstract] [Full Text] [Related]

  • 4. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes.
    Postlind H, DanielsonA, Lindgren A, Andersson SH.
    Drug Metab Dispos; 1998 Apr; 26(4):289-93. PubMed ID: 9531513
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of phencyclidine by human liver microsomes.
    Laurenzana EM, Owens SM.
    Drug Metab Dispos; 1997 May; 25(5):557-63. PubMed ID: 9152594
    [Abstract] [Full Text] [Related]

  • 6. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T.
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [Abstract] [Full Text] [Related]

  • 7. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
    Zhou S, Paxton JW, Tingle MD, Kestell P.
    Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
    [Abstract] [Full Text] [Related]

  • 8. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M, Shindo M, Shimada T.
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [Abstract] [Full Text] [Related]

  • 9. Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001).
    Kumar GN, Dubberke E, Rodrigues AD, Roberts E, Dennisen JF.
    Drug Metab Dispos; 1997 Jan; 25(1):110-5. PubMed ID: 9010637
    [Abstract] [Full Text] [Related]

  • 10. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [Abstract] [Full Text] [Related]

  • 11. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M, Suzuki H, Komiya I.
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
    Huskey SW, Dean DC, Miller RR, Rasmusson GH, Chiu SH.
    Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
    [Abstract] [Full Text] [Related]

  • 15. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
    Pichard L, Gillet G, Bonfils C, Domergue J, Thénot JP, Maurel P.
    Drug Metab Dispos; 1995 Nov; 23(11):1253-62. PubMed ID: 8591727
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
    Newton DJ, Wang RW, Lu AY.
    Drug Metab Dispos; 1995 Jan; 23(1):154-8. PubMed ID: 7720520
    [Abstract] [Full Text] [Related]

  • 17. Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor.
    Machinist JM, Mayer MD, Roberts EM, Surber BW, Rodrigues AD.
    Drug Metab Dispos; 1998 Oct; 26(10):970-6. PubMed ID: 9763401
    [Abstract] [Full Text] [Related]

  • 18. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
    Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, Benet LZ, Sewing KF, Christians U.
    Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
    Ling KH, Leeson GA, Burmaster SD, Hook RH, Reith MK, Cheng LK.
    Drug Metab Dispos; 1995 Jun; 23(6):631-6. PubMed ID: 7587944
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.